One of the best parts about the end of the year — outside of the holidays — is thinking about all of the events, goals and trends the following year will be filled with. As a commerce editor at NBC ...

Steven Daniels is a member of the University and College Union (UCU). The UK’s employment rights bill will usher in major changes for workers from April 2026. But beyond promising improved rights for ...

When you think back on your life so far, you’ll likely see a few pivotal moments that played a major role in your storyline. At the time, the events might not have seemed like a big deal — a haircut, ...

Something in the US economy isn’t adding up, and it’s rattling the people charged with wrangling inflation and keeping the labor market intact. US companies have sharply slowed their hiring this year, ...

Fashion trends move faster than Fashion Nova shipping — and even faster among the youth. Quicker than you can say “ski masks,” the kids have conjured an entirely new aesthetic: a quarter-zip sweater ...

Thanksgiving isn’t just an American thing anymore: it’s becoming a British obsession. Younger people in Britain are driving the trend. According to Mintel research, 42% of Gen Z and millennials in the ...

In this video interview, Hannah Bennett, head of travel at TikTok UK, discusses highlights from TikTok’s latest research exploring how traveler behavior is evolving and what these shifts mean for ...

LONDON, Oct 27 (Reuters) - British manufacturers are investing the least in new equipment relative to their sales since 2017, according to a report from trade body Make UK, which urged the government ...

LONDON, Oct 28 (Reuters) - Britain's budget watchdog is expected to cut a key productivity forecast by a larger-than-expected 0.3 percentage points, people familiar with the situation said, ...

After much fanfare, the spring 2026 shows are finally over. Now it’s up to us to parse through thousands of images and hundreds of reviews to decode their meaning. Did the great reset, as it’s been ...

The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...